Author Archives: BPI Contributor

Roundtable: New Approaches to Downstream Processing – Thinking Outside the Column

This recording features Moderator: Tom Ransohoff, Vice President and Senior Chair, BioProcess Technology Consultants Panelists: Robert S. Gronke, PhD, Senior Principle Scientist, Biogen Idec Mark Brower, Senior Research Chemical Engineer, Merck & Co. Tracy Thompson, Founder and CEO, PolyBatics Paul Jojorian, Senior Scientific Manager, Purification Development, Gallus BioPharmaceuticals Jim Stout, PhD., Vice President, Process Sciences, Natrix Separations

Harmonization of Single-Use Systems: Coordination of SUS Standards and Best Practice Efforts

This recording features Moderator: James Vogel, Founder and Director, The BioProcess Institute Panelists: Jay Ankers, Director of Technology, M&W Group (representing ASME-BPE) Jerold Martin, Senior Vice President, Global Scientific Affairs, Pall Corp (representing BPSA) Robert Steininger, Senior Vice President, Manufacturing, Acceleron Pharma (representing ASTM) Pietro Perrone, P.E., Single-Use Systems Engineer, EMD Millipore (representing ISPE)

Lonza and AMYRA Sign Comprehensive Development and Manufacturing Services Agreement for Enzyme-Based Treatment of Celiac Disease

Lonza • AMYRA Biotech AG to develop a rational oral treatment for celiac disease using a cocktail of two proprietary enzymes • Contract covers the process development and production of AMYRA’s two enzymes for the treatment of celiac disease • Lonza will develop and manufacture AMYRA’s enzymes in their Kourim, Czech Republic facility • Included in the contract is an XSâ„¢ Commercial License with access to Lonza’s XSâ„¢ Microbial Expression Technology Platform Basel and Zug, Switzerland, 10 April 2014 –…

EMD Millipore Introduces Incoming CEO and President

EMD Millipore Billerica, MA—April 9, 2013—EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, announces the appointment of Udit Batra, Ph.D. as its incoming President and CEO, responsible for the organization’s strategic direction to drive growth and product innovation as well as oversight of the worldwide operations. Dr. Batra will assume leadership effective May 15, 2014 and be based at the company’s U.S. headquarters in Massachusetts. “As a global leader in the Life Sciences industry, I am…

KrosFlo® Research IIi Tangential Flow Filtration System

Spectrum Laboratories’s the KrosFlo ®Research IIi Tangential Flow Filtration System (KRIIi) is the only commercially available system with hold up volumes as low as 1 milliliter. Spectrum’s innovative, semi-automated TFF System, is ideal for small volume, R&D scale microfiltration and ultrafiltration. The KRIIi system can be used to concentrate and wash, viruses, proteins, nano-particles, and cells, at low volumes, with remarkable recovery rates. Hollow Fiber Tangential Flow Filtration is fast becoming the preferred method of large and small scale processing, due to outstanding efficiency and easy scalability compared to cassette or centrifugal devices.

TOYOPEARL GigaCap® DEAE-650M Preserving Resolution at Increased Protein loads

TOYOPEARL GigaCap DEAE-650M is an ideal anion exchange resin for the chromatographic purification of biotherapeutic products. Since the TOYOPEARL GigaCap DEAE-650M has such a high dynamic binding capacity, the need for very large columns and massive buffer consumption is minimized, particularly for proteins expressed at higher levels due to upstream improvements.